SHP2 is required for BCR-ABL1-induced hematologic neoplasia

Autor: Gu, S, Sayad, A, Chan, G, Yang, W, Lu, Z, Virtanen, C, Van Etten, RA, Neel, BG

Publikováno v: Gu, S; Sayad, A; Chan, G; Yang, W; Lu, Z; Virtanen, C; et al.(2018). SHP2 is required for BCR-ABL1-induced hematologic neoplasia. Leukemia, 32(1), 203-213. doi: 10.1038/leu.2017.250. UC Irvine: Retrieved from: http://www.escholarship.org/uc/item/3866t0t6

© 2018 Macmillan Publishers Limited. BCR-ABL1-targeting tyrosine kinase inhibitors (TKIs) have revolutionized treatment of Philadelphia chromosome-positive (Ph+) hematologic neoplasms. Nevertheless, acquired TKI resistance remains a major problem in

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______325::a83709cbea09326a9456db5dab918499
http://www.escholarship.org/uc/item/3866t0t6

Effect of topical interferon-γ gene therapy using gemini nanoparticles on pathophysiological markers of cutaneous scleroderma in Tsk/+ mice.

Autor: Badea, I¹, Virtanen, C², Verrall, R E³, Rosenberg, A⁴, Foldvari, M⁵

Publikováno v: Gene Therapy. Oct2012, Vol. 19 Issue 10, p978-987. 10p.

Risk stratification using hotspot genotyping in low-grade serous ovarian cancer

Autor: Wohlmuth, C., Tone, A., Daghrach, A., Stickle, N., Virtanen, C., Brown, T.J., May, T.

Publikováno v: In Gynecologic Oncology October 2020 159 Supplement 1:36-37

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Iron-fortified and unfortified cow’s milk: Effects on iron intakes and iron status in young children

Autor: M A Virtanen, C J E Svahn, L U Viinik

Publikováno v: Acta Paediatrica. 90:724-731

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::bcea1ff8cc482aa36b4cc16c520d982c
https://doi.org/10.1080/08035250117907